NEW YORK (GenomeWeb) – Trovagene today announced that it is establishing a European subsidiary, Trovagene Research Institute, charged with expanding the capabilities and adoption of the company's Precision Cancer Monitoring platform.

Alberto Bardelli, a University of Torino liquid biopsy researcher, will serve as scientific chair of TRI, Trovagene said. Bardelli has also been a member of the company's scientific advisory board for the past year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.